Buyse, Marc

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study

Tournigand, C., André, T., Achille, E., Lledo, G., Flesh, M., Mery-Mignard, D., Quinaux, E., Couteau, C., Buyse, M., Ganem, G., et al. (2004) · Journal of Clinical Oncology

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 2,915

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials

Sargent, D. J., Wieand, H. S., Haller, D. G., Gray, R., Benedetti, J. K., Buyse, M., Labianca, R., Seitz, J. F., O'Callaghan, C. J., Francini, G., et al. (2005) · Journal of Clinical Oncology

Statistical Methods in Clinical TrialsColorectal Cancer Treatments and Studies

Cited by 713

Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis

Oba, K., Paoletti, X., Alberts, S., Bang, Y.-J., Benedetti, J., Bleiberg, H., Catalano, P., Lordick, F., Michiels, S., Morita, S., et al. (2013) · JNCI Journal of the National Cancer Institute

Gastric Cancer Management and OutcomesStatistical Methods in Clinical Trials

Cited by 168

Ensuring trial validity by data quality assurance and diversification of monitoring methods

Baigent, C., Harrell, F. E., Buyse, M., Emberson, J. R., & Altman, D. G. (2008) · Clinical Trials

Statistical Methods in Clinical TrialsEthics in Clinical Research

Cited by 163

Data fraud in clinical trials.

George, S. L., & Buyse, M. (2015) · Clinical Investigation

Academic integrity and plagiarismBenford’s Law and Fraud Detection

Cited by 126

Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients

Hurvitz, S. A., Betting, D. J., Stern, H. M., Quinaux, E., Stinson, J., Seshagiri, S., Zhao, Y., Buyse, M., Mackey, J., Driga, A., et al. (2012) · Clinical Cancer Research

HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 115

Alternative clinical end points in rectal cancer—are we getting closer?

Glynne-Jones, R., Mawdsley, S., Pearce, T., & Buyse, M. (2006) · Annals of Oncology

Colorectal Cancer Surgical TreatmentsStatistical Methods in Clinical Trials

Cited by 88

A randomized controlled trial of OPT-302, a VEGF-C/D inhibitor for neovascular age-related macular degeneration

Jackson, T. L., Slakter, J., Buyse, M., Wang, K., Dugel, P. U., Wykoff, C. C., Boyer, D. S., Gerometta, M., Baldwin, M. E., Price, C. F., et al. (2023) · Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 55

Adjuvant Therapy of Colorectal Cancer: Why We Still Don't Know

Buyse, M. (1988) · JAMA

Colorectal Cancer Surgical TreatmentsColorectal Cancer Treatments and Studies

Cited by 18

Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring

de Viron, S., Trotta, L., Schumacher, H., Lomp, H.-J., Höppner, S., Young, S., & Buyse, M. (2022) · Therapeutic Innovation & Regulatory Science

Benford’s Law and Fraud DetectionStatistical Methods in Clinical Trials

Cited by 16

Does Central Monitoring Lead to Higher Quality? An Analysis of Key Risk Indicator Outcomes

de Viron, S., Trotta, L., Steijn, W., Young, S., & Buyse, M. (2023) · Therapeutic Innovation & Regulatory Science

Statistical Methods in Clinical TrialsPharmacovigilance and Adverse Drug Reactions

Cited by 9

Does Central Statistical Monitoring Improve Data Quality? An Analysis of 1,111 Sites in 159 Clinical Trials

de Viron, S., Trotta, L., Steijn, W., Young, S., & Buyse, M. (2024) · Therapeutic Innovation & Regulatory Science

Statistical Methods in Clinical TrialsPharmacovigilance and Adverse Drug Reactions

Cited by 9